By Karen Iris Tucker
Regulatory hurdles plague a new class of cancer drugs that showed encouraging results. Those obstacles have frustrated carriers of cancer-causing mutations, for whom medicine might prove helpful.
Read More
By Karen Iris Tucker
There is no Jewish roadmap for how to properly mourn pets, nor any universal law or tradition for how to close the circle of a pet’s life, writes Karen Iris Tucker.
Read More
By Karen Iris Tucker
Sandra Bernhard is beloved for her withering onstage attacks. She’s more spiritual these days, trading kabbalah for shul, and building a home with her ‘cold WASP-y’ girlfriend.
Read More
By Karen Iris Tucker
Genetics has long been thought to play a relatively minor role when it comes to the development of Parkinson’s disease. So it came as a surprise to the medical community five years ago when Dr. Susan Bressman and her colleagues at the Beth Israel Medical Center in New York reported that a single genetic mutation in a gene called LRRK2 accounted for a significant portion of all cases of Parkinson’s disease among Ashkenazi Jews.
Read More
By Karen Iris Tucker
An emerging therapy that attacks cancer cells continues to show promise, most recently in two international studies on women who have breast and ovarian cancer and are carriers of cancer-causing mutations particularly prevalent among Ashkenazi Jews.Read More